Pharma & Healthcare

Global Psilocybin Assisted Therapy Market Insights, Forecast to 2030

The global Psilocybin Assisted Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Psilocybin Assisted Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Psilocybin Assisted Therapy, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Psilocybin Assisted Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psilocybin Assisted Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Psilocybin Assisted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Psilocybin Assisted Therapy sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Segment by Type
Natural
Synthetic
Segment by Application
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Psilocybin Assisted Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psilocybin Assisted Therapy sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Psilocybin Assisted Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Psilocybin Assisted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Natural
1.2.3 Synthetic
1.3 Market by Application
1.3.1 Global Psilocybin Assisted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cluster Headaches
1.3.3 Anxiety Disorders
1.3.4 Psychiatric Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts 2019-2030
2.2 Global Psilocybin Assisted Therapy Revenue by Region
2.2.1 Global Psilocybin Assisted Therapy Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Psilocybin Assisted Therapy Revenue by Region (2019-2024)
2.2.3 Global Psilocybin Assisted Therapy Revenue by Region (2025-2030)
2.2.4 Global Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2030)
2.3 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts 2019-2030
2.4 Global Psilocybin Assisted Therapy Sales by Region
2.4.1 Global Psilocybin Assisted Therapy Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Psilocybin Assisted Therapy Sales by Region (2019-2024)
2.4.3 Global Psilocybin Assisted Therapy Sales by Region (2025-2030)
2.4.4 Global Psilocybin Assisted Therapy Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Psilocybin Assisted Therapy Sales by Manufacturers
3.1.1 Global Psilocybin Assisted Therapy Sales by Manufacturers (2019-2024)
3.1.2 Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Psilocybin Assisted Therapy in 2023
3.2 Global Psilocybin Assisted Therapy Revenue by Manufacturers
3.2.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers (2019-2024)
3.2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Psilocybin Assisted Therapy Revenue in 2023
3.3 Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Psilocybin Assisted Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Psilocybin Assisted Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Psilocybin Assisted Therapy Sales by Type
4.1.1 Global Psilocybin Assisted Therapy Historical Sales by Type (2019-2024)
4.1.2 Global Psilocybin Assisted Therapy Forecasted Sales by Type (2025-2030)
4.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
4.2 Global Psilocybin Assisted Therapy Revenue by Type
4.2.1 Global Psilocybin Assisted Therapy Historical Revenue by Type (2019-2024)
4.2.2 Global Psilocybin Assisted Therapy Forecasted Revenue by Type (2025-2030)
4.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Psilocybin Assisted Therapy Price by Type
4.3.1 Global Psilocybin Assisted Therapy Price by Type (2019-2024)
4.3.2 Global Psilocybin Assisted Therapy Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Psilocybin Assisted Therapy Sales by Application
5.1.1 Global Psilocybin Assisted Therapy Historical Sales by Application (2019-2024)
5.1.2 Global Psilocybin Assisted Therapy Forecasted Sales by Application (2025-2030)
5.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
5.2 Global Psilocybin Assisted Therapy Revenue by Application
5.2.1 Global Psilocybin Assisted Therapy Historical Revenue by Application (2019-2024)
5.2.2 Global Psilocybin Assisted Therapy Forecasted Revenue by Application (2025-2030)
5.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Psilocybin Assisted Therapy Price by Application
5.3.1 Global Psilocybin Assisted Therapy Price by Application (2019-2024)
5.3.2 Global Psilocybin Assisted Therapy Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Psilocybin Assisted Therapy Market Size by Type
6.1.1 US & Canada Psilocybin Assisted Therapy Sales by Type (2019-2030)
6.1.2 US & Canada Psilocybin Assisted Therapy Revenue by Type (2019-2030)
6.2 US & Canada Psilocybin Assisted Therapy Market Size by Application
6.2.1 US & Canada Psilocybin Assisted Therapy Sales by Application (2019-2030)
6.2.2 US & Canada Psilocybin Assisted Therapy Revenue by Application (2019-2030)
6.3 US & Canada Psilocybin Assisted Therapy Market Size by Country
6.3.1 US & Canada Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Psilocybin Assisted Therapy Sales by Country (2019-2030)
6.3.3 US & Canada Psilocybin Assisted Therapy Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Psilocybin Assisted Therapy Market Size by Type
7.1.1 Europe Psilocybin Assisted Therapy Sales by Type (2019-2030)
7.1.2 Europe Psilocybin Assisted Therapy Revenue by Type (2019-2030)
7.2 Europe Psilocybin Assisted Therapy Market Size by Application
7.2.1 Europe Psilocybin Assisted Therapy Sales by Application (2019-2030)
7.2.2 Europe Psilocybin Assisted Therapy Revenue by Application (2019-2030)
7.3 Europe Psilocybin Assisted Therapy Market Size by Country
7.3.1 Europe Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Psilocybin Assisted Therapy Sales by Country (2019-2030)
7.3.3 Europe Psilocybin Assisted Therapy Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Psilocybin Assisted Therapy Market Size
8.1.1 China Psilocybin Assisted Therapy Sales (2019-2030)
8.1.2 China Psilocybin Assisted Therapy Revenue (2019-2030)
8.2 China Psilocybin Assisted Therapy Market Size by Application
8.2.1 China Psilocybin Assisted Therapy Sales by Application (2019-2030)
8.2.2 China Psilocybin Assisted Therapy Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Psilocybin Assisted Therapy Market Size by Type
9.1.1 Asia Psilocybin Assisted Therapy Sales by Type (2019-2030)
9.1.2 Asia Psilocybin Assisted Therapy Revenue by Type (2019-2030)
9.2 Asia Psilocybin Assisted Therapy Market Size by Application
9.2.1 Asia Psilocybin Assisted Therapy Sales by Application (2019-2030)
9.2.2 Asia Psilocybin Assisted Therapy Revenue by Application (2019-2030)
9.3 Asia Psilocybin Assisted Therapy Sales by Region
9.3.1 Asia Psilocybin Assisted Therapy Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Psilocybin Assisted Therapy Revenue by Region (2019-2030)
9.3.3 Asia Psilocybin Assisted Therapy Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MindMed
11.1.1 MindMed Company Information
11.1.2 MindMed Overview
11.1.3 MindMed Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 MindMed Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MindMed Recent Developments
11.2 Compass Pathways
11.2.1 Compass Pathways Company Information
11.2.2 Compass Pathways Overview
11.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Compass Pathways Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Compass Pathways Recent Developments
11.3 ATAI Life Sciences
11.3.1 ATAI Life Sciences Company Information
11.3.2 ATAI Life Sciences Overview
11.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ATAI Life Sciences Recent Developments
11.4 Field Trip
11.4.1 Field Trip Company Information
11.4.2 Field Trip Overview
11.4.3 Field Trip Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Field Trip Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Field Trip Recent Developments
11.5 DemeRx
11.5.1 DemeRx Company Information
11.5.2 DemeRx Overview
11.5.3 DemeRx Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 DemeRx Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DemeRx Recent Developments
11.6 Eleusis
11.6.1 Eleusis Company Information
11.6.2 Eleusis Overview
11.6.3 Eleusis Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Eleusis Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eleusis Recent Developments
11.7 Hikma Pharmaceuticals PLC
11.7.1 Hikma Pharmaceuticals PLC Company Information
11.7.2 Hikma Pharmaceuticals PLC Overview
11.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Pharmaceuticals PLC Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Pfizer Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Verrian
11.9.1 Verrian Company Information
11.9.2 Verrian Overview
11.9.3 Verrian Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Verrian Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Verrian Recent Developments
11.10 Jazz Pharmaceuticals
11.10.1 Jazz Pharmaceuticals Company Information
11.10.2 Jazz Pharmaceuticals Overview
11.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jazz Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Psilocybin Assisted Therapy Industry Chain Analysis
12.2 Psilocybin Assisted Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Psilocybin Assisted Therapy Production Mode & Process
12.4 Psilocybin Assisted Therapy Sales and Marketing
12.4.1 Psilocybin Assisted Therapy Sales Channels
12.4.2 Psilocybin Assisted Therapy Distributors
12.5 Psilocybin Assisted Therapy Customers
13 Market Dynamics
13.1 Psilocybin Assisted Therapy Industry Trends
13.2 Psilocybin Assisted Therapy Market Drivers
13.3 Psilocybin Assisted Therapy Market Challenges
13.4 Psilocybin Assisted Therapy Market Restraints
14 Key Findings in The Global Psilocybin Assisted Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Psilocybin Assisted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Natural
Table 3. Major Manufacturers of Synthetic
Table 4. Global Psilocybin Assisted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Psilocybin Assisted Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Psilocybin Assisted Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2024)
Table 9. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2025-2030)
Table 10. Global Psilocybin Assisted Therapy Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 12. Global Psilocybin Assisted Therapy Sales by Region (2025-2030) & (K Units)
Table 13. Global Psilocybin Assisted Therapy Sales Market Share by Region (2019-2024)
Table 14. Global Psilocybin Assisted Therapy Sales Market Share by Region (2025-2030)
Table 15. Global Psilocybin Assisted Therapy Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Psilocybin Assisted Therapy Sales Share by Manufacturers (2019-2024)
Table 17. Global Psilocybin Assisted Therapy Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Psilocybin Assisted Therapy Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Psilocybin Assisted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Psilocybin Assisted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2023)
Table 23. Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Psilocybin Assisted Therapy, Product Offered and Application
Table 25. Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 28. Global Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 29. Global Psilocybin Assisted Therapy Sales Share by Type (2019-2024)
Table 30. Global Psilocybin Assisted Therapy Sales Share by Type (2025-2030)
Table 31. Global Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Psilocybin Assisted Therapy Revenue Share by Type (2019-2024)
Table 34. Global Psilocybin Assisted Therapy Revenue Share by Type (2025-2030)
Table 35. Psilocybin Assisted Therapy Price by Type (2019-2024) & (USD/Unit)
Table 36. Global Psilocybin Assisted Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 38. Global Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 39. Global Psilocybin Assisted Therapy Sales Share by Application (2019-2024)
Table 40. Global Psilocybin Assisted Therapy Sales Share by Application (2025-2030)
Table 41. Global Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Psilocybin Assisted Therapy Revenue Share by Application (2019-2024)
Table 44. Global Psilocybin Assisted Therapy Revenue Share by Application (2025-2030)
Table 45. Psilocybin Assisted Therapy Price by Application (2019-2024) & (USD/Unit)
Table 46. Global Psilocybin Assisted Therapy Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 60. Europe Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 61. Europe Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 62. Europe Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 65. Europe Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 66. Europe Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 72. Europe Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 73. China Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 74. China Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 75. China Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 78. China Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 79. China Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 82. Asia Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 83. Asia Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 86. Asia Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 87. Asia Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Psilocybin Assisted Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Psilocybin Assisted Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 93. Asia Psilocybin Assisted Therapy Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 107. MindMed Company Information
Table 108. MindMed Description and Major Businesses
Table 109. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. MindMed Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. MindMed Recent Developments
Table 112. Compass Pathways Company Information
Table 113. Compass Pathways Description and Major Businesses
Table 114. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Compass Pathways Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Compass Pathways Recent Developments
Table 117. ATAI Life Sciences Company Information
Table 118. ATAI Life Sciences Description and Major Businesses
Table 119. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. ATAI Life Sciences Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. ATAI Life Sciences Recent Developments
Table 122. Field Trip Company Information
Table 123. Field Trip Description and Major Businesses
Table 124. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Field Trip Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Field Trip Recent Developments
Table 127. DemeRx Company Information
Table 128. DemeRx Description and Major Businesses
Table 129. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. DemeRx Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. DemeRx Recent Developments
Table 132. Eleusis Company Information
Table 133. Eleusis Description and Major Businesses
Table 134. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Eleusis Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Eleusis Recent Developments
Table 137. Hikma Pharmaceuticals PLC Company Information
Table 138. Hikma Pharmaceuticals PLC Description and Major Businesses
Table 139. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hikma Pharmaceuticals PLC Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Pfizer Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Verrian Company Information
Table 148. Verrian Description and Major Businesses
Table 149. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Verrian Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Verrian Recent Developments
Table 152. Jazz Pharmaceuticals Company Information
Table 153. Jazz Pharmaceuticals Description and Major Businesses
Table 154. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Jazz Pharmaceuticals Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Psilocybin Assisted Therapy Distributors List
Table 160. Psilocybin Assisted Therapy Customers List
Table 161. Psilocybin Assisted Therapy Market Trends
Table 162. Psilocybin Assisted Therapy Market Drivers
Table 163. Psilocybin Assisted Therapy Market Challenges
Table 164. Psilocybin Assisted Therapy Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Psilocybin Assisted Therapy Product Picture
Figure 2. Global Psilocybin Assisted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Psilocybin Assisted Therapy Market Share by Type in 2023 & 2030
Figure 4. Natural Product Picture
Figure 5. Synthetic Product Picture
Figure 6. Global Psilocybin Assisted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Psilocybin Assisted Therapy Market Share by Application in 2023 & 2030
Figure 8. Cluster Headaches
Figure 9. Anxiety Disorders
Figure 10. Psychiatric Disorders
Figure 11. Psilocybin Assisted Therapy Report Years Considered
Figure 12. Global Psilocybin Assisted Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Psilocybin Assisted Therapy Revenue 2019-2030 (US$ Million)
Figure 14. Global Psilocybin Assisted Therapy Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2030)
Figure 16. Global Psilocybin Assisted Therapy Sales 2019-2030 ((K Units)
Figure 17. Global Psilocybin Assisted Therapy Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Psilocybin Assisted Therapy Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Psilocybin Assisted Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Psilocybin Assisted Therapy Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Psilocybin Assisted Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Psilocybin Assisted Therapy Sales YoY (2019-2030) & (K Units)
Figure 23. China Psilocybin Assisted Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Psilocybin Assisted Therapy Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Psilocybin Assisted Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Psilocybin Assisted Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Psilocybin Assisted Therapy in the World: Market Share by Psilocybin Assisted Therapy Revenue in 2023
Figure 30. Global Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 32. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 33. Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 34. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Psilocybin Assisted Therapy Revenue Share by Country (2019-2030)
Figure 40. US & Canada Psilocybin Assisted Therapy Sales Share by Country (2019-2030)
Figure 41. U.S. Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 44. Europe Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 45. Europe Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 46. Europe Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 47. Europe Psilocybin Assisted Therapy Revenue Share by Country (2019-2030)
Figure 48. Europe Psilocybin Assisted Therapy Sales Share by Country (2019-2030)
Figure 49. Germany Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 50. France Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 54. China Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 55. China Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 56. China Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 57. China Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 58. Asia Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 59. Asia Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 60. Asia Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 61. Asia Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 62. Asia Psilocybin Assisted Therapy Revenue Share by Region (2019-2030)
Figure 63. Asia Psilocybin Assisted Therapy Sales Share by Region (2019-2030)
Figure 64. Japan Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 68. India Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Psilocybin Assisted Therapy Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Psilocybin Assisted Therapy Sales Share by Country (2019-2030)
Figure 75. Brazil Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Psilocybin Assisted Therapy Revenue (2019-2030) & (US$ Million)
Figure 80. Psilocybin Assisted Therapy Value Chain
Figure 81. Psilocybin Assisted Therapy Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies